Etesian Wealth Advisors, Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1997586 West Linn, OR

Position in GILD

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$1,228,151

-$204,433 QoQ

Shares Held

9,721

-5.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.36%

of 13F equity value

Holder Rank

#991

of 2,266 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Etesian Wealth Advisors, Inc. holds $8,238,349 across 4 Drug Manufacturers - General names. GILD ranks #3 (14.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,360	$4,030,085
2	ABBV	AbbVie Inc.	9,470	$2,383,030
3	GILD	Gilead Sciences, Inc. This page	9,721	$1,228,151
4	JNJ	Johnson & Johnson	2,351	$597,083

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,228,151	9,721	-5.4%	Shares	Sole	2026-07-23
2026-03-31	$1,432,584	10,279	-9.5%	Shares	Sole	2026-04-23
2025-12-31	$1,394,449	11,361	0.0%	Shares	Sole	2026-02-11
2025-09-30	$1,261,071	11,361	-1.5%	Shares	Sole	2025-10-23
2025-06-30	$1,278,663	11,533	-6.6%	Shares	Sole	2025-07-24
2025-03-31	$1,383,145	12,344	-2.9%	Shares	Sole	2025-04-24
2024-12-31	$1,173,837	12,708	-18.4%	Shares	Sole	2025-01-27
2024-09-30	$1,305,221	15,568	-9.5%	Shares	Sole	2024-10-18
2024-06-30	$1,179,886	17,197	-3.0%	Shares	Sole	2024-07-25
2024-03-31	$1,298,942	17,733	-3.2%	Shares	Sole	2024-04-15
2023-12-31	$1,483,941	18,318	+0.7%	Shares	Sole	2024-01-16
2023-09-30	$1,363,158	18,190	-1.9%	Shares	Sole	2024-01-16
2023-06-30	$1,429,417	18,547	-3.1%	Shares	Sole	2024-01-16
2023-03-31	$1,587,879	19,138	-1.7%	Shares	Sole	2024-01-16
2022-12-31	$1,671,499	19,470	—	Shares	Sole	2024-01-16
No filing history on record for this holder in this stock.